A dominant negative effect probably causes SPOP mutant forms associated with prostate cancer to be defective in promoting INF2 ubiquitination, resulting in increased localization of INF2 at the endoplasmic reticulum. This evidence concerns the gene SPOP and prostate carcinoma.